FDA-Approved Cancer Drugs Show Potential to Reverse Alzheimer’s Disease, New Study Finds

Researchers identify two FDA-approved cancer drugs, letrozole and irinotecan, that could potentially reverse Alzheimer’s disease, according to new findings from UCSF and Gladstone Institutes. Clinical trials may be imminent.